All lobbying filings

E3 STRATEGIC CONSULTING GROUP

Lobbying for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Association

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · Senate · $50,000.00 income · posted Jul 1, 2025

Official filing document

Bills named in this filing 2

S 1040
Drug Competition Enhancement Act
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…

Lobbying activity 1

Pharmacy

Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.